Healthcare Payors MCP Governance Build vs Buy | Moring
Building an MCP server is easy; running one reliably in a regulated payor environment is where costs hide. Identity, scoped authorization, audit trails, PHI handling, and gateway policy are the production requirements that turn a weekend prototype into governed infrastructure, and most payors buy more of that layer than they build.
Short answer
Building an MCP server is easy; running one reliably in a regulated payor environment is where costs hide. Identity, scoped authorization, audit trails, PHI handling, and gateway policy are the production requirements that turn a weekend prototype into governed infrastructure, and most payors buy more of that layer than they build.
How it works
The build-versus-buy question for MCP follows a familiar arc. Building a prototype is genuinely easy: a single server routing one agent to a few internal tools can be assembled over a weekend. Running it reliably in production is where the hidden costs proliferate, as enterprise infrastructure analyses describe: expired tokens at two in the morning, compliance teams asking where the connections came from, and a codebase that has become a distributed systems problem. Over sixteen thousand MCP servers now exist in the wild, and the demo-to-production gap is where most of them stall.
For a payor, the production requirements are heavier than average because member data is in the path. Security research on the protocol identifies the threat classes a production deployment must answer: content-injection attackers embedding malicious instructions in otherwise legitimate data, supply-chain attackers distributing compromised servers, and agents that over-step their roles. The corresponding controls, per-user authentication with scoped authorization, provenance tracking across agent workflows, sandboxing with input and output checks, and inline inspection, are exactly the layer that is expensive to build and cheap to adopt when it exists.
The build case is narrow and specific. A payor building its own MCP layer makes sense for a small number of internal servers wrapping proprietary systems where no vendor option exists, where the team can commit to the operational burden, and where the governance plane, identity, policy checks, and audit, is purchased or platform-provided rather than hand-built. The pattern that fails is building the governance plane itself, because static keys, missing attribution, and unlogged calls are the defaults of hand-rolled implementations.
The buy case rests on maturity. Gateway and governance platforms now bundle the primitives production requires: registry and approval of servers, per-agent identity with scoped credentials, pre-execution policy checks, and full audit trails. Governance guides for the protocol describe the same four concerns as the core of production governance, and healthcare-specific deployments add PHI handling requirements that generic tooling must be configured to honor, including inline redaction and immutable logs.
A hybrid is the realistic target state. Buy the control plane, build the thin server layer that exposes payor-specific systems, and hold every server, built or bought, to the same admission test: does it authenticate per agent, scope its grants, pass the policy gateway, and log every call attributably. Analysts of shadow MCP deployments note the alternative, ungoverned servers accumulating under desks, is already happening in organizations that adopted agents without a governance plan.
Whichever way the payor leans, the compliance artifacts are the same and the EU AI Act sets their standard: deployers of high-risk systems maintain traceability and oversight across the lifecycle. Build-versus-buy is therefore a question about who maintains those capabilities and at what cost, not whether they exist; the payor's job is to specify them in the requirements and verify them before go-live.
Frequently asked questions
What is the real cost difference between building and buying MCP infrastructure?
Building a server is cheap; operating it is not. Production adds identity, scoped authorization, audit trails, credential lifecycle, and reliability under load, and the failure pattern is well documented: prototypes stall in the demo-to-production gap while compliance teams ask where connections came from. Buying the governance plane and building only thin, payor-specific server wrappers concentrates internal effort where no vendor option exists.
Which MCP threats must a payor's deployment answer regardless of build or buy?
Three classes from security research: content-injection attackers embedding malicious instructions in legitimate data, supply-chain attackers distributing compromised servers, and agents over-stepping their roles. The matching controls are per-user authentication with scoped authorization, provenance tracking across workflows, sandboxing with input and output checks, and inline inspection. Healthcare deployments add PHI handling, inline redaction, and immutable audit logs as non-negotiable configuration requirements.
When is building the MCP layer justified for a payor?
For a small number of internal servers wrapping proprietary systems where no vendor option exists, with a team committed to the operational burden, and only when the governance plane itself, identity, policy enforcement, and audit, is platform-provided rather than hand-built. Hand-rolled governance defaults to static keys and missing attribution, which defeats auditability. Building the control plane from scratch is the pattern that fails in regulated environments.
What admission test should every MCP server pass, built or bought?
One standard: authenticate per agent rather than with static keys, scope grants per tool and action, pass through the policy gateway for pre-execution checks, and log every call with attributable identity and outcome. Servers that cannot meet it stay quarantined from member data regardless of origin. This single test aligns the portfolio with the traceability the EU AI Act expects deployers of high-risk systems to maintain.